The European Medicines Agency's strategies to meet the challenges of Alzheimer disease

被引：11

作者：

Haas, Manuel ^{[1
]}

Mantua, Valentina ^{[2
]}

Haberkamp, Marion ^{[3
]}

Pani, Luca ^{[2
]}

Isaac, Maria ^{[1
]}

Butlen-Ducuing, Florence ^{[1
]}

Vamvakas, Spiros ^{[1
]}

Broich, Karl ^{[3
]}

机构：

[1] European Meds Agcy, London E14 5EU, England

[2] Agenzia Italiana Farmaco, I-00187 Rome, Italy

[3] Bundesinstitut Arzneimittel & Medizinprodukte, D-53175 Bonn, Germany

来源：

NATURE REVIEWS DRUG DISCOVERY | 2015年 / 14卷 / 04期

关键词：

D O I：

10.1038/nrd4585

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Regulatory agencies have a key role in facilitating the development of new drugs for Alzheimer disease, particularly given the challenges associated with early intervention. Here, we highlight the strategies of the European Medicines Agency to help address such challenges.

引用

页码：221 / 222

页数：2

共 50 条

[31] Complementary and alternative medicines for Alzheimer's disease
Ott, BR
Owens, NJ
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 1998, 11 (04) : 163 - 173
[32] Challenges in drug development for central nervous system disorders: a European Medicines Agency perspective
Butlen-Ducuing, Florence
Petavy, Frank
Guizzaro, Lorenzo
Zienowicz, Malgorzata
Haas, Manuel
Alteri, Enrica
Salmonson, Tomas
Corruble, Emmanuelle
NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (12) : 813 - 814
[33] Review: UK medicines likely to be affected by the proposed European Medicines Agency’s guidelines on phthalates
Lisa Jamieson
William McCully
BMC Pharmacology and Toxicology, 16
[34] Dignity for Deeply Forgetful People: How Caregivers Can Meet the Challenges of Alzheimer's Disease
Waterman, Chloe
INTERNATIONAL JOURNAL OF CARE AND CARING, 2024,
[35] Review: UK medicines likely to be affected by the proposed European Medicines Agency's guidelines on phthalates
Jamieson, Lisa
McCully, William
BMC PHARMACOLOGY & TOXICOLOGY, 2015, 16
[36] Challenges in drug development for central nervous system disorders: a European Medicines Agency perspective
Florence Butlen-Ducuing
Frank Pétavy
Lorenzo Guizzaro
Malgorzata Zienowicz
Tomas Salmonson
Manuel Haas
Emmanuelle Corruble
Enrica Alteri
Nature Reviews Drug Discovery, 2016, 15 : 813 - 814
[37] Dignity for Deeply Forgetful People: How Caregivers Can Meet the Challenges of Alzheimer's Disease
Burroughs, Kristen
JOURNAL OF CONSUMER HEALTH ON THE INTERNET, 2022, 26 (03) : 334 - 335
[38] Dignity for Deeply forgetful people: How caregivers can meet the challenges of Alzheimer's Disease
Ren, Lily Haopu
Hung, Lillian
DEMENTIA-INTERNATIONAL JOURNAL OF SOCIAL RESEARCH AND PRACTICE, 2024, 23 (08): : 1416 - 1418
[39] Dignity for Deeply Forgetful People: How Caregivers Can Meet the Challenges of Alzheimer's Disease
Whitehouse, Peter J.
George, Daniel R.
JOURNAL OF ALZHEIMERS DISEASE, 2022, 90 (04) : 1831 - 1833
[40] Overview of the European Medicines Agency's Experience With Biowaivers in Centralized Applications
Lenic, Ines
Blake, Kevin
Garcia-Arieta, Alfredo
Potthast, Henrike
Welink, Jan
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2019, 12 (05): : 490 - 496

← 1 2 3 4 5 →